Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.

Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J.

J Med Virol. 2003 May;70(1):91-8.

PMID:
12629649
2.

Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Koraka P, Suharti C, Setiati TE, Mairuhu AT, Van Gorp E, Hack CE, Juffrie M, Sutaryo J, Van Der Meer GM, Groen J, Osterhaus AD.

J Clin Microbiol. 2001 Dec;39(12):4332-8.

3.

Serological markers during dengue 3 primary and secondary infections.

Vázquez S, Pérez AB, Ruiz D, Rodríguez R, Pupo M, Calzada N, González L, González D, Castro O, Serrano T, Guzmán MG.

J Clin Virol. 2005 Jun;33(2):132-7. Epub 2004 Dec 18.

PMID:
15911428
4.

Elevated levels of total and Puumala virus-specific immunoglobulin E in the Scandinavian type of hemorrhagic fever with renal syndrome.

Alexeyev OA, Ahlm C, Billheden J, Settergren B, Wadell G, Juto P.

Clin Diagn Lab Immunol. 1994 May;1(3):269-72.

5.

Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras.

De Rivera IL, Parham L, Murillo W, Moncada W, Vazquez S.

Am J Trop Med Hyg. 2008 Aug;79(2):262-6.

PMID:
18689634
6.

Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity.

Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J.

J Med Virol. 2004 Mar;72(3):445-50.

PMID:
14748068
7.

Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections.

Vázquez S, Cabezas S, Pérez AB, Pupo M, Ruiz D, Calzada N, Bernardo L, Castro O, González D, Serrano T, Sanchez A, Guzmán MG.

Int J Infect Dis. 2007 May;11(3):256-62. Epub 2006 Aug 17.

8.

A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roef C, Erlin, Sutaryo, Porter KR, Halstead SB.

Am J Trop Med Hyg. 1999 Sep;61(3):412-9.

PMID:
10497982
9.

Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.

Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD.

FEMS Immunol Med Microbiol. 2006 Oct;48(1):84-90.

10.

Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.

Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM.

J Infect Dis. 2008 Mar 15;197(6):817-24. doi: 10.1086/528805.

PMID:
18269315
11.

Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.

Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Lin TH, Huang JH.

J Med Virol. 2000 Oct;62(2):224-32.

PMID:
11002252
12.

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A.

J Infect Dis. 2000 Jan;181(1):2-9.

PMID:
10608744
13.

Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia.

Khan NA, Azhar EI, El-Fiky S, Madani HH, Abuljadial MA, Ashshi AM, Turkistani AM, Hamouh EA.

Acta Trop. 2008 Jan;105(1):39-44. Epub 2007 Sep 29.

PMID:
17983609
14.

Prospective study to determine accuracy of rapid serological assays for diagnosis of acute dengue virus infection in Laos.

Blacksell SD, Bell D, Kelley J, Mammen MP Jr, Gibbons RV, Jarman RG, Vaughn DW, Jenjaroen K, Nisalak A, Thongpaseuth S, Vongsouvath M, Davong V, Phouminh P, Phetsouvanh R, Day NP, Newton PN.

Clin Vaccine Immunol. 2007 Nov;14(11):1458-64. Epub 2007 Aug 22.

15.

Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.

Vazquez S, Acosta N, Ruiz D, Calzada N, Alvarez AM, Guzman MG.

J Virol Methods. 2009 Jul;159(1):6-9. doi: 10.1016/j.jviromet.2009.02.017. Epub 2009 Feb 24.

PMID:
19442837
16.

Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjørup I, Lopez-Velez R, Clerinx J, Peyerl-Hoffmann G, Sundøy A, Genton B, Kern P, Calleri G, de Górgolas M, Mühlberger N, Jelinek T; European Network on Surveillance of Imported Infectious Diseases.

J Infect Dis. 2007 Apr 15;195(8):1089-96. Epub 2007 Mar 2.

PMID:
17357044
17.
18.

Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Kliks SC, Nimmanitya S, Nisalak A, Burke DS.

Am J Trop Med Hyg. 1988 Mar;38(2):411-9.

PMID:
3354774
19.

Serodiagnosis of dengue virus infection in patients presenting to a tertiary care hospital.

Neeraja M, Lakshmi V, Teja VD, Umabala P, Subbalakshmi MV.

Indian J Med Microbiol. 2006 Oct;24(4):280-2.

20.

Seroprevalence of dengue virus antibodies in asymptomatic Costa Rican children, 2002-2003: a pilot study.

Iturrino-Monge R, Avila-Agüero ML, Avila-Agüero CR, Moya-Moya T, Cañas-Coto A, Camacho-Badilla K, Zambrano-Mora B.

Rev Panam Salud Publica. 2006 Jul;20(1):39-43.

PMID:
17018223

Supplemental Content

Support Center